These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

254 related items for PubMed ID: 23484857

  • 1. Agomelatine, melatonin and depressive disorder.
    Norman TR.
    Expert Opin Investig Drugs; 2013 Apr; 22(4):407-10. PubMed ID: 23484857
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Pathophysiology of depression: role of sleep and the melatonergic system.
    Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeggeler B, Cardinali DP.
    Psychiatry Res; 2009 Feb 28; 165(3):201-14. PubMed ID: 19181389
    [Abstract] [Full Text] [Related]

  • 4. Melatonergic drugs in clinical practice.
    Hardeland R, Poeggeler B, Srinivasan V, Trakht I, Pandi-Perumal SR, Cardinali DP.
    Arzneimittelforschung; 2008 Feb 28; 58(1):1-10. PubMed ID: 18368944
    [Abstract] [Full Text] [Related]

  • 5. Melatonin and melatonergic drugs on sleep: possible mechanisms of action.
    Srinivasan V, Pandi-Perumal SR, Trahkt I, Spence DW, Poeggeler B, Hardeland R, Cardinali DP.
    Int J Neurosci; 2009 Feb 28; 119(6):821-46. PubMed ID: 19326288
    [Abstract] [Full Text] [Related]

  • 6. Circadian rhythms, melatonin and depression.
    Quera Salva MA, Hartley S, Barbot F, Alvarez JC, Lofaso F, Guilleminault C.
    Curr Pharm Des; 2011 Feb 28; 17(15):1459-70. PubMed ID: 21476953
    [Abstract] [Full Text] [Related]

  • 7. Therapeutic potential of agomelatine in epilepsy and epileptic complications.
    Vimala PV, Bhutada PS, Patel FR.
    Med Hypotheses; 2014 Jan 28; 82(1):105-10. PubMed ID: 24314750
    [Abstract] [Full Text] [Related]

  • 8. Agomelatine in the tree shrew model of depression: effects on stress-induced nocturnal hyperthermia and hormonal status.
    Schmelting B, Corbach-Söhle S, Kohlhause S, Schlumbohm C, Flügge G, Fuchs E.
    Eur Neuropsychopharmacol; 2014 Mar 28; 24(3):437-47. PubMed ID: 23978391
    [Abstract] [Full Text] [Related]

  • 9. Agomelatine treatment corrects symptoms of depression and anxiety by restoring the disrupted melatonin circadian rhythms of rats exposed to chronic constant light.
    Tchekalarova J, Stoynova T, Ilieva K, Mitreva R, Atanasova M.
    Pharmacol Biochem Behav; 2018 Aug 28; 171():1-9. PubMed ID: 29807067
    [Abstract] [Full Text] [Related]

  • 10. The interaction between the internal clock and antidepressant efficacy.
    Racagni G, Riva MA, Popoli M.
    Int Clin Psychopharmacol; 2007 Oct 28; 22 Suppl 2():S9-S14. PubMed ID: 17917564
    [Abstract] [Full Text] [Related]

  • 11. Agomelatine: An Astounding Sui-generis Antidepressant?
    Naveed M, Li LD, Sheng G, Du ZW, Zhou YP, Nan S, Zhu MY, Zhang J, Zhou QG.
    Curr Mol Pharmacol; 2022 Oct 28; 15(7):943-961. PubMed ID: 34886787
    [Abstract] [Full Text] [Related]

  • 12. Role of melatonin in mood disorders and the antidepressant effects of agomelatine.
    Srinivasan V, De Berardis D, Shillcutt SD, Brzezinski A.
    Expert Opin Investig Drugs; 2012 Oct 28; 21(10):1503-22. PubMed ID: 22876742
    [Abstract] [Full Text] [Related]

  • 13. [Melatoninergic antidepressant valdoxan].
    Arushanian ÉB.
    Eksp Klin Farmakol; 2011 Oct 28; 74(7):41-5. PubMed ID: 21894769
    [Abstract] [Full Text] [Related]

  • 14. Like melatonin, agomelatine (S20098) increases the amplitude of oscillations of two clock outputs: melatonin and temperature rhythms.
    Castanho A, Bothorel B, Seguin L, Mocaër E, Pévet P.
    Chronobiol Int; 2014 Apr 28; 31(3):371-81. PubMed ID: 24328729
    [Abstract] [Full Text] [Related]

  • 15. [Development of a new antidepressant : agomelatine].
    Mocaër E, Delalleau B, Boyer PA, de Bodinat C.
    Med Sci (Paris); 2005 Oct 28; 21(10):888-93. PubMed ID: 16197911
    [Abstract] [Full Text] [Related]

  • 16. The mechanism, efficacy, and tolerability profile of agomelatine.
    MacIsaac SE, Carvalho AF, Cha DS, Mansur RB, McIntyre RS.
    Expert Opin Pharmacother; 2014 Feb 28; 15(2):259-74. PubMed ID: 24328686
    [Abstract] [Full Text] [Related]

  • 17. [Agomelatine: the first "melatoninergic" antidepressant].
    Bánki MC.
    Neuropsychopharmacol Hung; 2006 Oct 28; 8(3):105-12. PubMed ID: 17211046
    [Abstract] [Full Text] [Related]

  • 18. Agomelatine: innovative pharmacological approach in depression.
    Popoli M.
    CNS Drugs; 2009 Oct 28; 23 Suppl 2():27-34. PubMed ID: 19708723
    [Abstract] [Full Text] [Related]

  • 19. Beyond the monoaminergic hypothesis: agomelatine, a new antidepressant with an innovative mechanism of action.
    Kasper S, Hamon M.
    World J Biol Psychiatry; 2009 Oct 28; 10(2):117-26. PubMed ID: 19255935
    [Abstract] [Full Text] [Related]

  • 20. Agomelatine as chronopsychopharmaceutics restoring circadian rhythms and enhancing resilience to stress: a wishfull thinking or an innovative strategy for superior management of depression?
    Jakovljević M.
    Psychiatr Danub; 2011 Mar 28; 23(1):2-9. PubMed ID: 21448091
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.